Risk factors for in-hospital mortality of patients with high model for end-stage liver disease scores following living donor liver transplantation
- PMID: 22700628
Risk factors for in-hospital mortality of patients with high model for end-stage liver disease scores following living donor liver transplantation
Abstract
Background: Living donor liver transplantation (LDLT) for patients with high model for end-stage liver disease (MELD) scores is controversial due to its poor outcome. However, there is little information regarding which factor would negatively impact the outcome of patients with high MELD scores. The aim of this study was to identify factors associated with the in-hospital mortality of patients with high MELD scores after LDLT.
Material and methods: All patients with an MELD scores ≥ 20 who received LDLT from 2005 to 2011 were recruited for the present study. Pre- and intra-operative variables were retrospectively and statistically analyzed.
Results: A total of 61 patients were included in the current study. The overall 3-month survival rate was 82% for patients with high MELD scores. Preoperative renal dysfunction, hyponatremia, starting albumin level < 2.8 g/dL, preoperative renal replacement for severe renal failure, anhepatic period > 100 minutes and intraoperative red blood cell (RBC) transfusion ≥ 10 units were identified as potential risk factors by univariate analysis. However, only hyponatremia, preoperative dialysis and massive RBC transfusion were independent risk factors in a multivariate analysis. The 3-month survival rates of patients with two or more independent risk factors and patients with none or one risk factor were 91 and 25%, respectively. A significant difference was observed (P < 0.001).
Conclusion: Hyponatremia, preoperative dialysis and massive RBC transfusion were related to poor outcome for sicker patients. Patients with two or more of the above-mentioned risk factors and high MELD scores may exhibit extremely poor short-term survival.
Similar articles
-
Survival outcomes of right-lobe living donor liver transplantation for patients with high Model for End-stage Liver Disease scores.Hepatobiliary Pancreat Dis Int. 2013 Jun;12(3):256-62. doi: 10.1016/s1499-3872(13)60042-9. Hepatobiliary Pancreat Dis Int. 2013. PMID: 23742770
-
Predictors of patient survival following living donor liver transplantation.Hepatobiliary Pancreat Dis Int. 2011 Jun;10(3):248-53. doi: 10.1016/s1499-3872(11)60041-6. Hepatobiliary Pancreat Dis Int. 2011. PMID: 21669566
-
Risk factors for abdominal bleeding after living-donor liver transplant.Exp Clin Transplant. 2014 Oct;12(5):424-8. doi: 10.6002/ect.2013.0223. Epub 2014 Feb 25. Exp Clin Transplant. 2014. PMID: 24568675
-
Which recipient pretransplant factors, such as MELD, renal function, sarcopenia, and recent sepsis influence suitability for and outcome after living donor liver transplantation? A systematic review of the literature and expert panel recommendations.Clin Transplant. 2022 Oct;36(10):e14656. doi: 10.1111/ctr.14656. Clin Transplant. 2022. PMID: 35340054
-
Bone marrow-derived mesenchymal stem cell therapy for decompensated liver cirrhosis: a meta-analysis.World J Gastroenterol. 2014 Oct 14;20(38):14051-7. doi: 10.3748/wjg.v20.i38.14051. World J Gastroenterol. 2014. PMID: 25320545 Free PMC article. Review.
Cited by
-
Presence of Systemic Inflammatory Response Syndrome Predicts a Poor Clinical Outcome in Dogs with a Primary Hepatitis.PLoS One. 2016 Jan 25;11(1):e0146560. doi: 10.1371/journal.pone.0146560. eCollection 2016. PLoS One. 2016. PMID: 26808672 Free PMC article.
-
Massive blood transfusion after the first cut in liver transplantation predicts renal outcome and survival.Langenbecks Arch Surg. 2014 Apr;399(4):429-40. doi: 10.1007/s00423-014-1181-y. Epub 2014 Mar 30. Langenbecks Arch Surg. 2014. PMID: 24682384
-
Outcome of patients undergoing right lobe living donor liver transplantation with small-for-size grafts.World J Gastroenterol. 2014 Jan 7;20(1):282-9. doi: 10.3748/wjg.v20.i1.282. World J Gastroenterol. 2014. PMID: 24415883 Free PMC article.
-
Living Donor Liver Transplant is a Transparent Activity in India.J Clin Exp Hepatol. 2013 Mar;3(1):61-5. doi: 10.1016/j.jceh.2012.10.001. Epub 2012 Oct 13. J Clin Exp Hepatol. 2013. PMID: 25755472 Free PMC article. Review.
-
Impact of Integrating Insulin-Like Growth Factor 1 Levels into Model for End-Stage Liver Disease Score for Survival Prediction in Hepatocellular Carcinoma Patients.Oncology. 2020;98(12):836-846. doi: 10.1159/000502482. Epub 2020 Oct 7. Oncology. 2020. PMID: 33027788 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical